Literature DB >> 12361364

The use of induced sputum in clinical trials.

J C Kips1, M D Inman, L Jayaram, E H Bel, K Parameswaran, M M M Pizzichini, I D Pavord, R Djukanović, F E Hargreave, P J Sterk.   

Abstract

Mesh：

Year:  2002        PMID： 12361364     DOI： 10.1183/09031936.02.00004702

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN： 0904-1850


× No keyword cloud information.
  4 in total

1.  Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Timothy Ramsay; Chun Zhang; Zafrira Avnur; Tania Nikolcheva; Anthony Quinn
Journal:  Respir Res       Date:  2010-04-22

2.  Allergen-induced airway inflammation and its therapeutic intervention.

Authors:  Paul M O'Byrne
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

3.  Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.

Authors:  Van C Willis; M Kristen Demoruelle; Lezlie A Derber; Catherine J Chartier-Logan; Mark C Parish; Isabel F Pedraza; Michael H Weisman; Jill M Norris; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheum       Date:  2013-10

4.  Cell distribution and cytokine levels in induced sputum from healthy subjects and patients with asthma after using different nebulizer techniques.

Authors:  Sinem Koc-Günel; Ralf Schubert; Stefan Zielen; Martin Rosewich
Journal:  BMC Pulm Med       Date:  2018-07-13       Impact factor: 3.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.